About this trial
Ambient air temperatures in Asian, Latin American, African, and Pacific climate hotspots have broken record highs in 2024, driven by man-made climate change. Solutions are needed to reduce heat exposure in communities. Sunlight-reflecting cool roof coatings passively reduce indoor temperatures and energy use to protect home occupants from extreme heat. Occupants living in poor housing conditions globally - for example in informal settlements, slums, and low-socioeconomic households - are especially vulnerable to increased indoor heat exposure.
Heat exposure can instigate and worsen numerous physical, mental and social health conditions. The worst adverse health effects are being experienced in communities least able to adapt to heat exposure. By reducing indoor temperatures, cool roof use can promote physical, mental and social wellbeing in occupants.
The long-term research goal is to identify viable passive housing adaptation technologies with proven health and environmental benefits to reduce the burden of heat stress in communities affected by heat globally. To meet this goal, the investigators will conduct a cluster-randomized controlled trial to establish the effects of cool roof use on health, indoor environment and economic outcomes in five urban climate hotspots: Ouagadougou, Burkina Faso; Colima, Mexico; Ahmedabad, India; Niue; and Tavua, Fiji.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Permanent household resident.
Disqualifiers
Roof damage, inaccessible or instability of roof adversely affecting cool roof coating application.
Participant unable to provide written/verbal informed consent.
Trial design
Parallel
Treatments tested in this trial
Cool roof
Other interventionCool roofs are a sunlight reflecting roof coating that can reduce indoor temperature. Cool roofs have high solar reflectance (reflecting the ultraviolet and visible wavelengths of sunlight, reducing heat transfer to the surface of a roof) and high thermal emittance (radiating absorbed solar energy).
Treatment groups
Trial outcomes
Primary outcomes
Resting heart rate
Resting heart rate in beats per minute measured as the average of three readings in the left arm over one hour using Blip portable automated sphygmomanometers.
Blood glucose control
Three month average of blood glucose in mmol/mol measured as glycosylated hemoglobin (HbA1c) using capillary blood and the HemoCue® HbA1c 501 System.
Depression
Self-reported presence and frequency of symptoms of depression assessed using aggregate score of the Patient Health Questionnaire 9 (PHQ-9). Minimum score of 0 and a maximum score of 27 with a higher score meaning a worse outcome.
Secondary outcomes
Heat-related symptoms
Self-reported heat-related symptoms in the past month, assessed using a recall questionnaire.
Physician diagnosed heat-related illnesses
Self-reported new diagnosis from a medical practitioner of a heat-related illness in the last month assessed using a recall questionnaire.
Food insecurity
Self-reported experience based measure of individual food security assessed using the Food Insecurity Experience Scale (FIES).
Diet quality
Self-reported individual food group consumption in the previous 24 hours assessed using the Diet Quality Questionnaire (DQQ).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Aditi Bunker
Lead sponsor
University of Auckland, New Zealand
Sponsor institution
Sika Services AG
Collaborator
SOPREMA
Collaborator
Engineered Polymer Solutions (EPS B.V.)
Collaborator
Resene
Collaborator
Pacific Community
Collaborator
Habitat for Humanity
Collaborator
The Tindall Foundation
Collaborator
Rutgers University
Collaborator
Boston University
Collaborator
London School of Hygiene and Tropical Medicine
Collaborator
Heidelberg University
Collaborator
University of Ouagadougou, Burkina Faso
Collaborator
Indian Institute of Public Health, India
Collaborator
Fiji National University
Collaborator
Universidad de Colima
Collaborator